Management tracks

Gene therapy company bluebird bio Inc. (NASDAQ:BLUE) said CFO Jim DeTore resigned,

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE